Almutairi Mashan, Hefnawy Amr, Almotairy Ahmed, Alobaida Ahmed, Alyahya Mohammed, Althobaiti Abdulmajeed, Adel Ali Youssef Ahmed, Elkanayati Rasha M, Ashour Eman A, Smyth Hugh D C, Repka Michael A
Department of Pharmaceutics and Drug Delivery, School of Pharmacy, The University of Mississippi, University, MS 38677, USA; Department of Pharmaceutics, College of Pharmacy, University of Hail, Hail 81442, Saudi Arabia.
Division of Molecular Pharmaceutics and Drug Delivery, College of Pharmacy, The University of Texas at Austin, 2409 University Avenue, Austin, TX, USA.
Int J Pharm. 2024 Apr 25;655:124044. doi: 10.1016/j.ijpharm.2024.124044. Epub 2024 Mar 23.
In recent years, several techniques were employed to develop a local sustained pulmonary delivery of sildenafil citrate (SC) as an alternative for the intravenous and oral treatment of pulmonary arterial hypertension (PAH). Most of these methods, however, need to be improved due to limitations of scalability, low yield production, low drug loading, and stability issues. In this study, we report the use of hot-melt extrusion (HME) as a scalable process for making Poly (lactic-co-glycolic acid) (PLGA) microparticles with high SC load. The prepared particles were tested in vitro for local drug delivery to the lungs by inhalation. Sodium bicarbonate was included as a porogen in the formulation to make the particles more brittle and to impart favorable aerodynamic properties. Six formulations were prepared with different formulation compositions. Laser diffraction analysis was used to estimate the geometric particle size distribution of the microparticles. In-vitro aerodynamic performance was evaluated by the next-generation cascade impactor (NGI). It was reported in terms of an emitted dose (ED), an emitted fraction (EF%), a respirable fraction (RF%), a fine particle fraction (FPF%), a mass median aerodynamic diameter (MMAD), and geometric standard deviation (GSD). The formulations have also been characterized for surface morphology, entrapment efficiency, drug load, and in-vitro drug release. The results demonstrated that PLGA microparticles have a mean geometric particle size between 6 and 14 µm, entrapment efficiency of 77 to 89 %, and SC load between 17 and 33 % w/w. Fifteen percent of entrapped sildenafil was released over 24 h from the PLGA microparticles, and seventy percent over 7 days. The aerodynamic properties included fine particle fraction ranging between 19 and 33 % and an average mass median aerodynamic diameter of 6-13 µm.
近年来,人们采用了多种技术来开发局部持续肺部递送枸橼酸西地那非(SC),作为肺动脉高压(PAH)静脉和口服治疗的替代方法。然而,由于可扩展性、产量低、药物载量低和稳定性问题等限制,这些方法大多需要改进。在本研究中,我们报告了使用热熔挤出(HME)作为一种可扩展的工艺来制备具有高SC载量的聚(乳酸-乙醇酸)(PLGA)微粒。通过吸入对制备的微粒进行体外肺部局部给药测试。配方中加入碳酸氢钠作为致孔剂,使微粒更脆,并赋予良好的空气动力学性能。制备了六种具有不同配方组成的制剂。采用激光衍射分析来估计微粒的几何粒径分布。通过下一代撞击器(NGI)评估体外空气动力学性能。报告内容包括发射剂量(ED)、发射分数(EF%)、可吸入分数(RF%)、细颗粒分数(FPF%)、质量中值空气动力学直径(MMAD)和几何标准差(GSD)。还对制剂的表面形态、包封率、药物载量和体外药物释放进行了表征。结果表明,PLGA微粒的平均几何粒径在6至14μm之间,包封率为77%至89%,SC载量在17%至33% w/w之间。15%的包封西地那非在24小时内从PLGA微粒中释放,7天内释放70%。空气动力学性能包括细颗粒分数在19%至33%之间,平均质量中值空气动力学直径为6 - 13μm。